Results Of Studies Using PSivida Technologies In Glaucoma And Degenerative Eye Diseases To Be Presented At Upcoming ARVO Meeting

pSivida Corp. (NASDAQ:PSDV)(ASX:PVA), a leader in the development of back of the eye drug delivery systems, today announced that two poster presentations will be made at the upcoming ARVO meeting on one of pSivida’s next generation bioerodible technologies for degenerative eye disease…

More: continued here

Filed under: Eye Health on May 1st, 2010